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Abstract: There are increasing data demonstrating the role of 18F-flourodeoxyglucose positron emission tomography 
with computerized tomography fusion (18F-FDG PET/CT) in the diagnosis of large vessel vasculitis, including Takayasu 
arteritis and giant cell arteritis. We report a case of large vessel vasculitis detected on 18F-FDG PET/CT; a 32-year-old 
woman with history of Non Hodgkin Lymphoma, admitted with fever of unknown origin (FUO) of 2-months duration and 
asthenia. To exclude FUO of malignancy, in the suspect of NHL relapse, 18F-FDG PET/CT imaging was performed. The 
images demonstrated significant 18F-FDG uptake in aortic arch and no signs of NHL relapse. This case report supports 
the role of 18F-FDG PET/CT as a useful and noninvasive tool in diagnostic evaluation of patient with FUO, both by 
excluding a malignant etiology and providing information about other possible causes such as inflammation, including 
vasculitis. 18F-FDG PET/CT is very useful in the early diagnosis of active inflammation including vasculitis and provides 
timely information for appropriate therapy. 
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INTRODUCTION 
Vasculitis is an inflammatory condition of the blood 
vessels, characterized by a leukocyte infiltration of the 
vessel wall causing reactive destruction of the wall 
structures and surrounding tissue leading to infarction. 
It is classified according to the vessel size (large-size, 
medium-size and small-size vessel vasculitis) [1]. 
Fluorine-18-fluorodeoxy-glucose positron emission 
tomography with computerized tomography fusion 
(18F-FDG PET/CT) has a confirmed role in the 
diagnosis and management of oncological diseases, 
but literature evidence suggests a new role for 18F-
FDG PET/CT also in the diagnosis of inflammatory 
processes such as vasculitis [2].  
The diagnosis of vasculitis is challenging because 
clinical manifestations are non-specific, featuring fever, 
fatigue, weight loss, diffuse pain, myalgia, etc.; it is 
based on the history, clinical examination, and 
laboratory analysis and imaging findings. The role of 
imaging is to detect vasculitis and to guide biopsy, the 
gold standard for the definitive diagnosis [3]. 
18F-FDG PET/CT can be particularly useful in patients 
with a previous history of oncological diseases who 
develop fever of unknown origin (FUO). We report the 
case of a patient previously treated for Non Hodgkin's 
Lymphoma (NHL) referred to our attention for FUO and 
suspected NHL relapse. 
 
 
*
Address correspondence to this author at the Nuclear Medicine Unit – D.I.M., 
University of Bari “Aldo Moro”, Italy; Tel: +39 0805592913;  
Fax: +39 0805592983; E-mail: artor.niccoliasabella@uniba.it 
CASE REPORT 
We report the case of a 32-year-old female 
hospitalized for a 2-months history of FUO and 
asthenia. 
She had been previously diagnosed, in March 2011, 
with a large cell B NHL after right supraclavicular lymph 
node biopsy. A chemotherapy protocol with Aracytin + 
Bleomycin + Vincristine + Methotrexate was started 
and the patient achieved full remission in the same 
year.  
On examination she appeared conscious, oriented, 
and well hydrated, with no skin lesions, BP 125/70 
mmHg, a regular HR 85 per minute, an axillary 
temperature of 38.0 °C and blood sugar 115 mg/dl. 
Cardiac and pulmonary physical examinations were 
unremarkable. Abdominal examination showed no 
clinical signs of peritoneal irritation or masses other 
than mild spleen enlargement. Bilateral renal 
percussion was negative.  
Further investigations showed normochromic 
normocytic anemia, with hemoglobin 8.9 g/dl (normal 
range for adult women 9-12 g/dl), WBC count 4.2x10
9
/L 
(normal range 4.3-10.8x10
9
/L), with 85.3% neutrophils, 
platelet count 185x10
9
/L (normal range 150-400x10
9
/L), 
ESR 125 mm/h (normal value <5mm/h), C-reactive 
protein 2.7 mg/dl (normal range 0–1 mg/dl) and beta2-
microglobulin 2.63 mg/L (normal range 1.16-2.52 
mg/L). Clotting indexes were within normal range. 
Renal function, serum electrolytes, lipid profile, liver 
indices, thyroid hormones, electrocardiogram and chest 
X-rays were normal. 
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On the suspicion of NHL relapse, whole body 18F-
FDG-PET/CT was performed with the Discovery STE 
scanner (General Electric Healthcare, Milwaukee, WI – 
USA). After at least 6 hours of fasting, an 18F-FDG 
dose of 265 MBq (4.2 MBq per kg of body weight) was 
administered intravenously and the PET/CT scans 
were recorded 45 minutes later.  
A significantly increased 18F-FDG uptake 
(enhanced metabolic activity) was evident in a 
circumferential pattern along the aortic arch (Figure 1). 
No 18F-FDG uptake was observed in the lymph nodes. 
These findings excluded NHL relapse and 
suggested a vasculitis. 
The patient was treated with a high dose 
corticosteroid regimen (1mg/kg). Her symptoms 
improved and the fever gradually resolved. Blood tests 
repeated on the 22
nd
 day after the start of treatment 
showed normalization of the inflammation indexes. 
DISCUSSION 
We present the case of a patient with vasculitis, 
probably Takayasu’s arteritis (TA), diagnosed with 18F-
FDG-PET/CT. Large vessels vasculitis forms include 
giant-cell arteritis (GCA) and Takayasu’s arteritis (TA). 
GCA is more common in elderly females, mainly 
affecting the supra-aortic arteries, most commonly the 
superficial temporal artery [4]; TA is predominantly 
observed in young women, most commonly involving 
the aorta and its branches [5].  
The American College of Rheumatology has 
defined specific criteria to support the diagnosis, based 
on symptoms presenting in advanced disease. In initial 
TA the broad variety of non-specific symptoms, and 
variable severity and progression, often hamper a 
precise evaluation, delaying diagnosis [6-7].  
The imaging techniques employed to diagnose 
vasculitis is Doppler ultrasound, MRI and CT 
angiography, which can show vessel wall thickening, 
thrombus, calcifications and luminal stenosis. 
Angiography, considered as the gold standard imaging 
technique, has high sensitivity but low specificity. It can 
detect an abnormal vascular anatomy but cannot 
define the reason for the vascular restriction 
(inflammation vs. fibrosis) [8]. Furthermore, it is 
invasive and associated with a high morbidity, 
exposure to radiation, as well as possible contrast 
toxicity [9]. 
18F-FDG PET/CT is a non-invasive diagnostic 
technique which can disclose, in patients with FUO, the 
disease onset earlier than traditional anatomical 
imaging techniques, thus allowing prompt treatment, 
which may delay or prevent the vessels stenosis. Webb 
et al., in patients with biopsy-proven TA who had 
undergone 18F-FDG-PET/CT, cross-sectional imaging 
 
Figure 1: 18F-FDG PET/CT transaxial CT (A), PET (B), fusion (C) images show a significantly increased 18F-FDG uptake in a 
circumferential pattern along the aortic arch (red arrows). MIP images (D) do not show 18F-FDG uptake in lymph nodes and 
spleen.  
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(contrast-enhanced CT and MRI) and angiography, 
demonstrated 92% sensitivity, 100% specificity, and 
negative and positive predictive values of 85% and 
100%, respectively, using 18F-FDG-PET/CT in the 
initial assessment of active vasculitis in TA [6].  
18F-FDG PET/CT has already been validated to 
assess patients with different types of malignant 
tumors, including lymphomas. 18F-FDG PET/CT 
evaluates central metabolic pathways changes in 
cancer cells, which present higher levels of glycolysis, 
an elevated glucose uptake, and increased lactate 
production compared to non-malignant cells, a 
phenomenon known as "aerobic glycolysis" [10]. 
18F-FDG PET/CT scanning has been found useful 
in the staging and follow-up of Hodgkin’s and non-
Hodgkin’s lymphoma [11-12], as well as in our patient 
who underwent 18F-FDG PET/CT for suspected NHL 
relapse. 
The uptake of 18F-FDG in patients with NHL is 
firstly ascribable to neoplastic tissue, especially if the 
uptake is located in the lymph nodes and spleen. Occa- 
sionally 18F-FDG uptake is not specific for malignant 
tumors, because inflammation and infections can also 
trigger an increased glucose metabolism [13-14]. 
In fact, in our patient 18F-FDG-PET/CT did not 
reveal an altered uptake in lymph nodes or spleen, thus 
excluding NHL relapse, whereas there was 18F-FDG 
uptake in the aortic arch, indicating the intense 
metabolism associated with active inflammation, and 
thus suggesting an inflammatory disease. The final 
diagnosis was based on the combination of clinical 
signs, laboratory data and 18F-FDG-PET/CT findings, 
compatible with large vessel arteritis (probably TA). 
CONCLUSIONS 
This case report supports the role of 18F-FDG 
PET/CT as a useful and non-invasive tool in the 
diagnostic evaluation of a patient with FUO, both to 
exclude a malignant etiology and to gain information 
about other possible causes such as inflammation. 
18F-FDG PET/CT is very useful in the early 
diagnosis of active inflammation, including vasculitis, 
and provides timely information supporting appropriate 
treatment decision-making.  
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